Banque Transatlantique Sa Context Therapeutics Inc. Call Options Transaction History
Banque Transatlantique Sa
- $5.69 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CNTX
# of Institutions
47Shares Held
79MCall Options Held
0Put Options Held
0-
Bio Impact Capital LLC Cambridge, MA14.7MShares$10.1 Million1.66% of portfolio
-
Avidity Partners Management LP Dallas, TX7.48MShares$5.16 Million1.03% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.42MShares$5.12 Million0.16% of portfolio
-
Nextech Invest, Ltd. Zurich, V87.42MShares$5.12 Million1.06% of portfolio
-
Nextech Invest Ag7.42MShares$5.12 Million1.37% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $11M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...